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http://dx.doi.org/10.1016/j.jmii.2013Background: Porcine circovirus type 2 (PCV2) is one of the major swine viral diseases and has
caused significant economic loss to pig producers. PCV2 has been divided into two major geno-
types: PCV2a, PCV2b. A loop-mediated isothermal amplification (LAMP) method was developed
for the detection and differentiation of PCV2a and PCV2b in clinical samples.
Methods: LAMP-specific primer sets were designed based on six PCV2a and six PCV2b reference
isolates. To determine the analytical specificity of LAMP, DNA samples extracted from 36
porcine virus isolates were tested by LAMP, including eight PCV2a, 11 PCV2b, four PCV type
1, two porcine parvovirus, three pseudorabies virus, and eight porcine reproductive and respi-
ratory virus. To evaluate the analytical sensitivity of the assay, 10-fold serial dilutions of PCV2a
and PCV2b recombinant plasmids were performed to prepare the dilutions at concentrationstitute of Molecular and Comparative Pathobiology, School of Veterinary Medicine, National Taiwan
evelt Road, Taipei 106, Taiwan.
stitute of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Number 1,
, Taiwan.
(S.-S. Lai), crjeng@ntu.edu.tw (C.-R. Jeng).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
.05.003
364 C. Wang et al.from 106 to 1 copy(ies)/mL, and each dilution was tested by both LAMP and nested polymerase
chain reaction (nested PCR). A total of 168 clinical samples were analyzed by both LAMP and
nested PCR, and the relative sensitivity and specificity of LAMP compared to nested PCR were
calculated.
Results: Using different primer sets of LAMP, LAMP could be completed within 50 minutes. This
method was found to be highly analytically specific for PCV2a and PCV2b; only the target gene
was detected without cross-reaction. The analytical sensitivity of LAMP for PCV2a and PCV2b
were 10 copies/mL, demonstrating analytical sensitivity comparable to that obtained using
nested PCR. In addition, the sensitivity and specificity of LAMP relative to those of nested
PCR were 97.7% and 100.0%, respectively. The percentage of observed agreement was
98.2%, and the k statistic was 0.949.
Conclusion: LAMP is a rapid, specific, and sensitive diagnostic method for the detection and
differentiation of PCV2a and PCV2b in clinical samples.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
In recent years, porcine circovirus type 2 (PCV2) has
emerged as a major swine viral pathogen, and its associ-
ated diseases cause significant economic losses in the swine
industry worldwide.1e3 This virus has been considered as
the causative agent of postweaning multisystemic wasting
syndrome (PMWS) as well as other clinical syndromes,
including porcine dermatitis and nephropathy syndrome
(PDNS), congenital tremor, porcine respiratory disease
complex, and proliferative and necrotizing pneumonia.4e6
All of these associated syndromes have been categorized
as PCV2-associated disease (PCVAD).7
Porcine circovirus type 2 is a non-enveloped, circular
single-stranded DNA virus belonging to the Circoviridae
family.8 This virus has three major open reading frames
(ORFs): ORF1, ORF2, and ORF3.8,9 ORF1 is believed to
encode the replication-associated protein,8 ORF2 encodes a
major structural capsid protein,10e12 and ORF3 encodes a
protein associated with cellular apoptosis.9 This virus is
divided into three major genotypes, PCV2a, PCV2b, and
PCV2c, according to phylogenetic analyses of the whole
genomic or ORF2 region.13e15 Although PCV2 was detected
in most of the pig herds studied, unique differences in the
clinical manifestation of PMWS have led to the hypothesis
that PCV2a and PCV2b may vary in virulence or replication
ability.16e19 In addition, PCV2c was isolated only in
Denmark in the 1980s and has not been connected to dis-
ease.20 The global genetic shift from PCV2a to PCV2b has
been discovered in many countries,1,17,21,22 but the
detailed mechanism of this phenomenon remains unclear.23
According to genomic sequenceanalysis ofPCV2 isolates, a
major specific motif in the ORF2 gene is useful for differen-
tiating between PCV2a and PCV2b.13e15 PCV2a and PCV2b
have the specific motif sequences AAAATC and CCCCG/TC,
respectively, at nucleotide positions 1474e1469 in the ORF2
region.13 Various diagnostic systems were developed that
depend on the specific motif for the detection and differen-
tiation of PCV2, including polymerase chain reaction (PCR),
nested PCR, real-time PCR, nucleotide sequencing, and re-
striction fragment length polymorphism (RFLP).1,13,14,24,25 In
addition, loop-mediated isothermal amplification (LAMP) isan excellent clinical diagnostic tool with advantages of high
specificity, less time-consuming, and easy performance to
detect specific nucleic acid sequence in clinical samples.26e29
Various pathogenic microorganisms can be detected in clin-
ical samples by incubating the template sample with specific
LAMP primer sets and Bst DNA polymerase with strand
displacement activity.26e29 The procedure entails incubating
the DNA extracted from clinical samples with the aforemen-
tioned reagents at a constant temperature of 60e65C for up
to 1 hour. As LAMP progresses, pyrophosphate ions (the re-
action byproduct) bind to magnesium ions to form a white
precipitate of magnesium pyrophosphate, resulting in an
increased turbidity that correlates with the amount of DNA
synthesized. The amplification can be monitored in real time
by detecting the increase in the turbidity in the reaction
mixture.30,31 LAMP has been used successfully to PCV2 DNA in
clinical samples.32e34 The purpose of this study was to
develop a LAMP protocol for detecting and differentiating
PCV2a and PCV2b in clinical samples.Materials and methods
Viruses and clinical samples
To evaluate the analytical specificity of this method, 36
virus isolates were used, comprising eight PCV2a, 11 PCV2b,
four PCV type 1 (PCV1), two porcine parvovirus (PPV), three
pseudorabies virus (PRV), and eight porcine reproductive
and respiratory virus (PRRSV), and all of the isolates were
identified by determining their partial nucleotide se-
quences as described previously.33,35 The DNA of PCV2a,
PCV2b, PCV1, PPV, and PRV and the cDNA of PRRSV isolates
were produced as described previously33,35 and stored at
e20C until use or used immediately for this study. For
comparison of the detection efficiency of LAMP, 168 clinical
lymph node tissue samples collected from pigs who became
dyspneic and emaciated between 2001 and 2011 were
employed. The total DNA from tissue samples was extrac-
ted using the QIAamp DNA Extraction Kit (Qiagen, Valencia,
CA, USA).
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Using the LAMP Primer Explorer V4 system (Eiken, Tokyo,
Japan), LAMP-specific primer sets of targeting the ORF2
gene were designed based on six PCV2a reference isolates
(AB072302, AF117753, AF264040, AF264043, AF364094, and
AF465211) and six PCV2b reference isolates (AF201897,
AY321997, AY682996, GQ911550, HQ202967, and HQ20
2972). The LAMP primer sets contained outer primers (F3,
B3) and inner primers (FIP, BIP). The inner primer FIP con-
tained the sequence complementary to F1 (F1c), a TTTT
bridge and F2. The inner primer BIP contained the sequence
complementary to B1 (B1c), a TTTT bridge and B2. To
further confirm validation of LAMP, nested PCR targeting
the ORF2 gene of PCV2a and PCV2b was employed using the
primers VF-2, Nest-R, 2a-F, 2a-R, 2b-F, and 2b-R.25 Nucle-
otide sequences and locations for each of the primers are
shown in Table 1.
LAMP reaction
A 25-mL reaction mixture consisted of 12.5 mL 2 LAMP
reaction buffer (Eiken), 1 mL Bst DNA polymerase (Eiken),
2 mL DNA, 40 pmol each of FIP and BIP primers, and 5 pmol
each of the F3 and B3 primers for PCV2a and PCV2b. LAMP
was performed by incubating the reaction mixture at 65C
for 50 minutes and then inactivating the Bst DNA poly-
merase by heating the mixture to 80C for 2 minutes. The
reaction was monitored in real time at 6-second intervals
by measuring the turbidity at A650 using a LA-320 real-time
turbidimeter (Eiken). The results were determined within
50 minutes, and turbidity at A650 above 0.1 was interpreted
as positive using the LA-320 software package (LA-320;Table 1 Oligonucleotide primer sets used for LAMP and nested
Primer Positiona Type
LAMP PCV2a-F3 1379e1396 Forward ou
PCV2a-B3 1589e1572 Backward o
PCV2a-FIP 1474e1451
1408e1423
Forward inn
F1c-TTTT-F
PCV2a-BIP 1487e1506
1561e1543
Backward in
B1c-TTTT-B
PCV2b-F3 1378e1393 Forward ou
PCV2b-B3 1606e1588 Backward o
PCV2b-FIP 1474e1457
1410e1429
Forward inn
F1c-TTTT-F
PCV2b-BIP 1516e1537
1587e1572
Backward in
B1c-TTTT-B
Nested PCR VF-2 62e79 First forwar
Nest-R 1555e1537 First Revers
2a-F 916e934 Second forw
2a-R 1483e1467 Second Rev
2b-F 1121e1138 Second forw
2b-R 1480e1464 Second Rev
a Location of the primers based on the nucleotide sequence of t
HQ202972) reference isolates.
b The major specific motif of PCV2a (AAAATC) and PCV2b (CCCCG/T
c The inner primers of FIP and BIP contained two binding regions coEiken). LAMP products were also analyzed by electropho-
resis through a 2% agarose gel containing 0.5 mg/mL SYBR
Safe DNA gel stain (Invitrogen, Carlsbad, CA, USA) in
TriseacetateeEDTA (ethylenediamine tetraeacetic acid)
solution.Nested PCR reaction
For the first round of PCR in the nested PCR, the 25-mL PCR
reaction mixture consisted of 2.5 mL 10 buffer (100 mM
TriseHCl at pH 8.8, 500 mM KCl, 15 mM MgCl2, 1% Triton X-
100), 1.25 mM each of four nucleoside triphosphates, 20 mM
each of VF-2 and Nest-R primers, 0.5 mL DNA polymerase
POWER TAQ (2 U/mL; Bertec, Taipei, Taiwan), and 2 mL DNA
sample. The first round of PCR was performed at 94C for 5
minutes followed by 30 cycles of denaturation at 94C for
30 seconds, annealing at 54C for 30 seconds, and extension
at 72C for 40 seconds. Finally, the samples were subjected
to a terminal extension step at 72C for 10 minutes. After
this reaction, a 2-mL first-round PCR product was used as a
template for nested PCR. In nested PCR, each 25-mL reac-
tion mixture consisted of 2.5 mL 10 buffer (100 mM
TriseHCl at pH 8.8, 500 mM KCl, 15 mM MgCl2, 1% Triton X-
100), 1.25 mM each of four nucleoside triphosphates, 0.5 mL
DNA polymerase POWER TAQ (2 U/mL; Bertec), and 20 mM
PCV2a (2a-F/2a-R) and PCV2b (2b-F/2b-R) primers. Nested
PCR was performed at 94C for 5 minutes followed by 30
cycles of denaturation at 94C for 30 seconds, annealing at
57C for 30 seconds, and extension at 72C for 30 seconds.
Finally, the samples were subjected to a terminal extension
step at 72C for 10 minutes. Products of nested PCR were
analyzed by electrophoresis through a 2% agarose gel as
aforementioned.PCR
Sequence (50e30)
ter GCC CAC TCC CCT ATC ACC
uter CTC CCG CAC CTT CGG ATA
er
2
AAA ATCb TCT ATA CCC TTT GAA TAC-TTTTc-GGG
AGC AGG GCC AGA A
ner
2
TCC CGG GGG AAC AAA GTC GT -TTTTc-CGT ACC
ACA GTC ACA ACG C
ter GCC CAC TCC CCT GTC A
uter CAT CTT CAA CAC CCG CCT C
er
2
CCC CG/TCb TCT GTG CCC TTT- TTTTc-AGC AGG
GCC AGA ATT CAA CC
ner
2
TCT CAT CAT GTC CAC CGC CCA G-TTTTc-TCC
CGC ACC TTC GGA T
d GAA GAA TGG AAG AAG CGG
e ACA GTC AGA ACG CCC TCC T
ard AAC AAT CCA CGG AGG AAG G
erse GGG ACC AAC AAA TCT CY
ard CTG TTT TCG AAC GCA GTG
erse CTC AAA CCC CCG CTC TG
he ORF2 gene of PCV2a (AF465211) and PCV2b (HQ202967 and
C) are highlighted in boldface.
nnected by a TTTT bridge.
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Full-length ORF2 gene of PCV2a (GenBank accession num-
ber AF465211) and PCV2b (GenBank accession number
HQ202967) were amplified as described previously.11 PCV2a
and PCV2b amplicons were ligated into the pCRII-TOPO
plasmid that was supplied with the Dual Promoter TOPO
TA Cloning Kit (Invitrogen). Top10F Escherichia coli
competent cells (Invitrogen) were transformed with PCV2a
and PCV2b recombinant plasmids according to the manu-
facturer’s instructions. The inserted target gene carried by
recombinant plasmids were directly sequenced as
described previously.3 These recombinant plasmids were
quantified by measuring its absorbance A260 on a U2100 pro
UV/Vis spectrophotometer (General Electronic Healthcare,
Singapore) and diluted to 106 copies/mL to develop a
standard curve for evaluating the analytical sensitivity of
LAMP.
Analytical specificity and sensitivity of LAMP
DNA samples extracted from the 36 virus isolates were
tested using LAMP to determine the analytical specificity of
the method. DNA extracted from specific pathogen-free
swine tissue samples was used as the negative control. To
evaluate the analytical sensitivity of the assay, 10-fold se-
rial dilutions of PCV2a and PCV2b recombinant plasmids
were performed to prepare the dilutions at concentrations
from 106 to 1 copy(ies)/mL, and each dilution was tested by
both LAMP and nested PCR. To quantify the diluted sam-
ples, the standard curves were generated for PCV2a LAMP
and PCV2b LAMP, where serial 10-fold dilutions of PCV2a
and PCV2b recombinant plasmids were positive for the
target gene on the x-axis and the time of positivity (mi-
nutes) on the y-axis.
Evaluation of LAMP with clinical samples
A total of 168 clinical samples were analyzed by both LAMP
and nested PCR, and the relative sensitivity and specificity
of LAMP compared to nested PCR were calculated as
described previously.27 The sensitivity of LAMP relative to
that of nested PCR was calculated as 100%  (number ofFigure 1. Analytical specificity of PCV2a LAMP (A) and PCV2b LA
3000e100 bp ladder marker (50 U/mL; Protec, Taipei, Taiwan); lan
respectively; lane 7, negative control.true positives)/(number of true positives þ number of false
negatives), and the relative specificity of LAMP was calcu-
lated as 100%  (number of true negatives)/(number of true
negatives þ number of false positives). The percentage of
observation agreement was calculated as 100%  (number
of true positives þ number of true negatives)/(number of
total clinical samples). Agreement among tests was based
on k statistics36 and was classified by k statistic values into
five groups: almost perfect (0.81 or higher), substantial
(0.61e0.8), moderate (0.41e0.6), fair (0.21e0.4), slight
(0.01e0.2), and poor (0).Results
Analytical specificity of LAMP
The analytical specificity of LAMP was evaluated using DNA
extracted from PCV2a, PCV2b, PCV1, PPV, and PRV and
cDNA from PRRSV. The PCV2a (Fig. 1A) and PCV2b (Fig. 1B)
LAMP procedures successfully detected specific PCV2a
(Fig. 1A, lane 1) and PCV2b (Fig. 1B, lane 2) target DNA
without cross-reaction and generated ladder-like products,
respectively.
Analytical sensitivity of LAMP
Using 10-fold serial dilutions of PCV2a and PCV2b recom-
binant plasmids, PCV2a (Fig. 2A) and PCV2b (Fig. 2B) LAMP
procedures can detect target DNA up to 10 copies/mL for
PCV2a (Fig. 2A, lane 6) and PCV2b (Fig. 2B, lane 6),
respectively, which was comparable to the detection of
PCV2a (Fig. 2C, lane 6) and PCV2b (Fig. 2D, lane 6) DNA by
nested PCR. Real-time monitoring of turbidity allowed for
the detection of PCV2a (Fig. 3A) and PCV2b (Fig. 3B) re-
combinant plasmids of 106 copies/mL as early as 19 minutes
after initiation of the reaction, with 10 copies/mL of PCV2a
and PCV2b recombinant plasmids detected in less than 50
minutes. The standard curve for LAMP was generated from
amplification plots of 10-fold serial dilutions (ranging from
106 to 10 copies/mL) of PCV2a (Fig. 3A) and PCV2b (Fig. 3B)
recombinant plasmids versus time (minutes). Linear
regression lines with coefficients of r2 Z 0. 987 and 0.961MP (B) was observed using agarose gel electrophoresis. Lane M,
es 1e6 represent PCV2a, PCV2b, PCV1, PPV, PRV, and PRRSV,
Figure 2. Analytical sensitivity of LAMP (A, B) and nested PCR (C, D) was performed by detecting 10-fold serial dilutions of PCV2a
and PCV2b recombinant plasmids. The LAMP products for PCV2a and PCV2b are represented in (A) and (B), respectively. The nested
PCR products for PCV2a (C) and PCV2b (D) are 568 and 360 base pairs (bp) in length, respectively. Lane M, 3000e100 bp ladder
marker (50 U/mL; Portec); lanes 1e7 represent 106, 105, 104, 103, 102, 10, and 1 copy(ies)/mL recombinant plasmids, respectively;
lane 8, negative control.
Figure 3. Analytical sensitivity of PCV2a LAMP (A) and PCV2b LAMP (B) was performed by real-time monitoring with 10-fold serial
dilutions of PCV2a and PCV2b recombinant plasmids and negative control (NC). The plot of the mean threshold time against the log
of the input 106 to 10 copies/mL of PCV2a (C) and PCV2b (D) recombinant plasmids fit linear function is shown.
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Table 3 Detection and differentiation of PCV2a and
PCV2b by both LAMP and nested PCR in 168 clinical samples
Nested PCR LAMP
PCV2aþ PCV2ae PCV2bþ PCV2be
PCV2aþ (n Z 47) 44 3 0 47
PCV2bþ (n Z 68) 0 68 68 0
PCV2a and PCV2bþ
(n Z 16)
16 0 16 0
Negative (n Z 37) 0 37 0 37
368 C. Wang et al.were plotted for PCV2a (Fig. 3C) and PCV2b (Fig. 3D) LAMP
results, respectively.
Evaluation of LAMP with clinical samples
Of 168 clinical samples, 128 samples were positive for PCV2
as detected by both LAMP and nested PCR, 37 samples were
negative for PCV2 as detected by both LAMP and nested
PCR, and 3 samples were in disagreement with positive
results obtained by nested PCR and with negative results by
LAMP (Table 2). Using the results of nested PCR as gold
standard, the relative sensitivity of LAMP compared to
nested PCR was 97.7%, and the relative specificity of LAMP
compared to nested PCR was 100% (Table 2). The percent-
age of observed agreement was 98.2%, and the k statistic
was 0.949 (Table 2). Among PCV2 positive samples, 44
samples were positive for PCV2a, 68 samples were positive
for PCV2b, and 16 samples were dual positive for PCV2a and
PCV2b (Table 3). Only three samples were in disagreement
with positive results by nested PCR and with negative re-
sults by LAMP for PCV2a (Table 3).
Discussion
In this study, LAMP can detect PCV2 DNA without being
time-consuming, which is much faster than other diagnostic
methods. Amplification of a specific genomic region by PCR,
nested PCR, and RFLP has been previously used to confirm
the accuracy of amplification for the detection and differ-
entiation of PCV2 DNA.1,13,14,24,25 However, conventional
detection procedures for PCV2 require to be completed
without being time-consuming. After preparation of sample
DNA, LAMP could be completed within 50 minutes, whereas
other methods required several hours to a few days. In
addition, LAMP products were analyzed not only by agarose
gel electrophoresis, but also with a turbidimeter, which
provided real-time analysis of increased turbidity of mag-
nesium pyrophosphate precipitate that correlates with the
amount of DNA. LAMP can also be used in quantitative
detection of virus copy number followed by standard curves
that were constructed (Fig. 3).
LAMP also demonstrated high analytical specificity for
the detection and differentiation of PCV2a and PCV2b in
clinical samples. Using different sets of LAMP primers,
specific regions of PCV2a and PCV2b genomes were ampli-
fied without cross-reaction. No amplification was observedTable 2 Comparison of detection ability of LAMP and
nested PCR in 168 clinical samplesa
LAMP Nested PCR Total n
Positive Negative
Positive 128 0 128
Negative 3 37 40
Total n 131 37 168
a Relative sensitivity and specificity are 97.7% (128/
131  100%) and 100% (37/37  100%), respectively. Percentage
of observed agreement is 98.2% (128 þ 37/168  100%). k sta-
tistic is 0.949.when LAMP was used to detect other swine viral pathogens
such as PCV1, PPV, PRV, and PRRSV. These results also
indicated that the major specific motif of the ORF2 gene
could be utilized for a LAMP-based genotyping procedure.
The major specific motif was located in the FIP primer
(Table 2, highlighted in boldface), and only the target gene
containing homologous nucleotide sequences could be
amplified when using LAMP-based major specific motif
typing. The LAMP method differentiated specific motifs of
the PCV2 ORF2 gene at each cycling step of replication, and
the genotype could be detected by amplifying the target
gene containing the major specific motif. Therefore, LAMP
was an excellent and reliable technique for rapid differ-
entiation to distinguish two genotypes of PCV2 from other
viral types in clinical samples. A similar method has also
been developed for differentiation of the long and short
shelf life of melons.37
In this study, LAMP was shown to have high analytical
sensitivity comparable to that of nested PCR (Fig. 2). LAMP
and nested PCR can detect PCV2a and PCV2b DNA down to
10 copies/mL, indicating that there is no difference in
analytical sensitivity between LAMP and nested PCR. It has
been widely considered that LAMP was one of the most
sensitive methods for PCV2 detection. Owing to its high
sensitivity, LAMP could detect and differentiate low
amounts of PCV2a and PCV2b DNA in clinical samples, and
can be used for further studies of PCV2 infection.
LAMP also showed high relative specificity and sensitivity
for the detection and differentiation of PCV2a and PCV2b in
168 clinical samples compared to nested PCR (Table 3). The
k statistic value, which was higher than 0.9 for PCV2, in-
dicates a strong correlation between nested PCR and LAMP
for the 168 clinical samples tested. Three disagreement
clinical samples were positive by nested PCR and negative
by LAMP (Table 3). The reason why the LAMP method missed
the three infected clinical samples is unclear. One expla-
nation may be that the three missed infected clinical
samples contained mutations that caused mismatches be-
tween the target gene and LAMP primers of PCV2a.
Furthermore, the ability to distinguish between two
genotypes of PCV2 has been important for the laboratory
diagnosis of PCV2, because different genotypes of PCV2
were found in isolates from pigs affected by PMWS and
other PCVAD. Coinfection of PCV2a and PCV2b in clinical
samples has been suggested as the cause,24 dual heterolo-
gous infection of PCV2a and PCV2b in gnotobiotic pigs has
been shown to induce severe clinical syndromes.38 How-
ever, when isolates from dually infected pigs were
sequenced, only the predominant PCV2 genotype was
Development and evaluation of LAMP for detection and differentiation of two genotypes of PCV2 369detected. The development of LAMP may provide an
alternative to PCR sequencing for the study of PCV2 path-
ogenesis infection, especially in cases of coinfection with
PCV2a and PCV2b in clinical samples. LAMP may also be an
alternative to other diagnostic methods for research of the
pathogenesis of PCV2 infection, which includes tissue dis-
tribution, viral load, and the routes of viral shedding. Thus,
this method should be an effective tool for further studies
on chronological changes in viral prevalence, such as the
gradual replacement of PCV2a with PCV2b in the pig pop-
ulation since 2003.1,17,21,22
Recently, all PCV2 commercial vaccines are based on
PCV2a genotype.39 A dramatic switch in genotype from
genotype PCV2a to PCV2b has been observed since 2003 and
the viruses of PCV2a and PCV2b may have some antigenic
differences.1,17,21,22 However, previous studies indicated
that all commercial vaccines can develop immune response
against PCV2b infection and have been shown to be
significantly effective in decreasing mortality and
increasing growth parameters in the pig population.18,39 In
addition, two major vaccination strategies have been
available. One strategy is to vaccinate breeding sows,
increasing high PCV2-neutralizing antibodies in colostrum,
and providing maternal antibodies to partially protect pig-
lets against virus infection.18,39 Another strategy is to
vaccinate healthy growing piglets greater than 3e4 weeks
of age to induce PCV2-specific neutralizing antibodies
against PCV2 infection.18,39,40
In conclusion, LAMP is a rapid, specific, sensitive, and
less time-consuming method. This method may also be used
in PCV2 studies in various areas, including epidemiology and
pathogenesis. LAMP appears to be more functional than all
other existing assays and may be suitable for routine lab-
oratory diagnosis, both for the detection and the differ-
entiation of PCV2.Conflicts of interest
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